Background/Aims: The colorectal neoplasia differentially expressed (CRNDE) gene is a long noncoding RNA (lncRNAs) that is upregulated in colorectal cancer and glioma. Here, we investigated the regulatory function of CRNDE in gastric cancer (GC). Methods: CRNDE and miR-145 expression were assayed by qRT-PCR, and E2F3 protein expression was measured by western blotting. A luciferase reporter assay was used to detect the direct regulation of miR-145 by CRNDE. Cell viability and colony formation of human GC cells were detected using MTT and colony formation assay, respectively. Results: CRNDE was highly expressed in GC cell lines and tissues; overexpression of CRNDE increased GC cell viability and promoted colony formation. Knockdown of CRNDE did not result in loss of expression-related effects on cell proliferation and colony formation. Further investigation revealed that the miR-145 target gene E2F3 was strongly expressed following CRNDE competitive molecular sponging of miR-145. Conclusion: CRNDE acted as a growth-promoting lncRNA in GC and maybe a potential target of GC treatment.
Introduction
Gastric cancer (GC) is the second most common cause of death from cancer worldwide [1] . Despite advances in therapy, the overall survival rate of patients with advanced GC is low. Long noncoding RNAs (lncRNAs) are transcripts that are longer than 200 nucleotides and have no protein coding function [2] . Some lncRNAs are known to be involved in complex mechanisms underlying the development of malignancies, including carcinogenesis, progression, and metastasis [3, 4] , but the underlying molecular events are unknown.
Many lncRNAs regulate gene expression at several levels including transcription and post-transcriptional processing [5] . In a recently described regulatory mechanism, lncRNAs behave as competing endogenous RNAs (ceRNAs), acting as molecular sponges of microRNAs (miRNAs) to derepress miRNA targets [6] . For example, the lncRNA MALAT1 functions as a ceRNA to regulate cell division control (Cdc) 42 expression by sponging the miR-1 in human breast cancer [7] . H19 contributes to gallbladder cancer cell proliferation by modulating miR-194-5p targeting of AKT2 [8] . LncRNA UCA1, a ceRNA of miR-193a-3p, is active in nonsmall cell lung cancer carcinogenesis, and may be a potential target of antineoplastic therapy [9] . These findings suggest the involvement of lncRNAs in GC tumorigenesis.
Colorectal neoplasia differentially expressed (gene symbol CRNDE) is a non-proteincoding human gene locus that is upregulated in colorectal adenomas and carcinomas [10] . CRNDE transcripts are lncRNAs, a class of noncoding RNA having more than 200 base pairs. The lncRNA CRNDE is thought to be involved in tumorigenesis because its expression is increased in several cancers including colorectal and ovarian cancer, glioma, and hepatocellular carcinoma [11] . However, CRNDE activity has not been previously reported in GC.
In this study, we found that upregulation of CRNDE in GC cells and tissues were associated with increased GC cell viability and promotion of colony formation. Our analysis indicated that CRNDE functioned as a ceRNA to regulate the expression of E2F transcription factor 3 (E2F3) by competing for miR-145 binding and thereby promoting GC growth. This study adds to our understanding of GC pathogenesis.
Materials and Methods

Tissue collection
Twenty pairs of GC tissues and adjacent nonmalignant gastric tissue samples were obtained from Huashan Hospital (Shanghai, China). The study was approved by the Research Ethics Committee of the Medical Ethics Committee of Huashan Hospital. Informed consent was obtained from all patients. Specimens were immediately snap-frozen in liquid nitrogen and stored at −80 °C until processing.
Cell culture
The SGC7901, BGC823, MGC803, and AGS human gastric cancer cell lines and GES-1 normal gastric epithelial cell line were obtained from the Chinese Institute of Biochemistry and Cell Biology (Shanghai, China). Cells were cultured in RPMI 1640 Medium (Invitrogen, Carlsbad, CA, USA) containing 10% fetal bovine serum, 100 U/ml penicillin, and 100 U/ml streptomycin in culture flasks at 37°C with 5% CO 2 .
Quantitative real-time PCR (qRT-PCR)
Total RNA was extracted from cells and tissue samples using TRIzol reagent (Invitrogen, California, USA), following the manufacturer's instructions. Complementary DNA synthesis was performed using Prime Script reverse transcriptase reagent kit (TaKaRa, Dalian, China) according to the manufacturer's instructions; RNA was reverse transcribed to cDNA with a reverse transcription kit (TaKaRa, Dalian, China); and CRNDE, miR-145; and E2F3 expression were assayed by qRT-PCR using SYBR Premix Ex Taq (TaKaRa, Dalian, China). The PCR primer sequences used are listed as the following: CRNDE: 5′-GTAGGATGCCACTG-GAAATG-3′ and 5′-CTGCGTGACAACTGAGGATT-3′; MiR-145: 5′-CAGTGCGTGTCGTGGAGT-3′ and 5′-AGGTC-CAGTTTTCCCAGG-3′; E2F3: 5′-ATATCCCTAAACCCGCTTCC-3′ and 5′-TGGTCCTCAGTCTGTAAGA-3′; mRNA, lncRNA, and miRNA expression were normalized against human GAPDH and U6 small nuclear (sn)RNA. Fold-change in expression was calculated by the relative quantification (2 −ΔΔCt ) method.
Lentivirus infection and establishment of stable cell lines
Lentivirus expressing CRNDE, short hairpin (sh) RNA targeting CRNDE and their corresponding controls were purchased from GenePharma (Shanghai, China), named LV-CRNDE and LV-shCRNDE. The sequence of shCRNDE and negative control (NS) were shown: shCRNDE: 5′-CACCGGAAGGAGGAGATTCT-GAAGATTCAAGAGATCTTCAGAATCTCC TCCTTCCTTTTTG-3′, NS: 5′-CACCGTTCTCCGAACGTGTCACGTCAA-GAGATTACGTG ACACGTTCGGAGAATTTTTTG-3′ [12] . SGC-7901, BGC-823 and GES-1 cells were transduced with the recombinant lentivirus, and stable cell lines were established. miR-145 mimics were also obtained from GenePharma.
Western blotting
Western blotting was performed as previously described [13] . Total protein was extracted from cells using RIPA lysis buffer (Beyotime, Jiangsu, China). Samples of cell lysate protein were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred onto polyvinylidene fluoride (PVDF) membranes. After blocking with 5% non-fat milk in TBS-T, proteins were then labelled with anti-E2F3 and anti-GAPDH (Cell Signaling Technology, Beverly, MA, USA) primary and secondary antibodies and detected with Image Acquisition using Image Quant™ LAS 4000 (GE Healthcare Life Sciences, Michigan, USA).
Cell proliferation assay
Cell proliferation was measured by 3-(4, 5-dimethylthiazole-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay and colony formation. For the MTT assay, LV-infected cells were seeded into 96-well plates at a density of 2000 cells/well and cultured for 24, 48, or 72 hours. The spectrophotometric absorbance of each well was measured at 490 nm at different time points using a microplate reader absorbance test plate (Molecular Devices, Sunnyvale, CA, USA). The colony formation assay was assayed as previously described [14] . Briefly, infected cells were seeded into six-well plates at a density of 500 cells per well and cultured at 37ºC with 5% CO 2 humidified air for 2 weeks. Colonies were fixed and stained with 0.1% crystal violet (1 mg/ml), and the number of colonies was counted by light microscopy. The experiment was performed in triplicate and repeated 3 times. Plate efficiency = (colony numbers / inoculated cell numbers) × 100%.
Luciferase reporter assay CRNDE fragments containing the putative binding sequence of miR-145 and its mutant sequence was cloned into a pGL3-control vector (Promega, Madison, WI, USA). The resulting vectors were sequenced and named CRNDE-WT, CRNDE-Mut. SGC7901 and BGC823 cells were cotransfected with the appropriate reporter plasmid, miRNA or pRL-TK Renilla plasmid (Promega) using Lipofectamine 2000 (Invitrogen). Luciferase activity was measured 48h post-transfection using a dual-luciferase reporter assay system (Promega) following the manufacturer's instructions.
RNA immunoprecipitation (RIP)
To determine whether CRNDE was associated with the RNA-induced silencing complex (RISC), RNA immunoprecipitation (RIP) was performed using an EZ-Magna RIP RNA-binding protein immunoprecipitation kit (Millipore, Billerica, MA, USA) following the manufacturer's instructions. SGC7901 and BGC823 cell lysates containing CRNDE and miRNAs were prepared and incubated with RIP buffer containing magnetic beads conjugated to human anti-argonaute2 (Ago2) antibody (Millipore). Normal mouse IgG (Millipore) was used as a negative control. CRNDE and miRNAs present in the precipitates were assayed by qRT-PCR.
Statistical analysis
Data were reported as means ± standard deviation (SD) and analyzed using SPSS 17.0 software (SPSS Inc., Chicago, IL, USA). Between-group differences were tested for significance using Student's t-test and one-way analysis of variance. Pearson correlation coefficients were calculated to determine the significance of the relationship of CRNDE and miR-145 expression. P-values <0.05 were considered significant.
Results
CRNDE expression is increased in human GC tissue and cell lines
The level of lncRNA CRNDE expression was first examined in GC tissues and matched adjacent normal tissue samples. As shown in Fig. 1A , CRNDE expression was significantly higher in GC tissues than in normal tissue. When CRNDE expression in SGC-7901, BGC823, MGC-803, AGS and GES-1 cell lines was assayed by qRT-PCR, CRNDE expression was found to be significantly higher in GC cells than in normal GES-1 gastric epithelial cells (Fig. 1B) . Collectively, the results showed that CRNDE was upregulated in GC.
CRNDE promoted cell proliferation in GC
To determine whether CRNDE regulated GC cell proliferation, we performed an in vitro gain and loss of function analyses of overexpression and silencing of CRNDE in SGC-7901 and BGC-823 gastric cancer cells ( Fig. 2A and C) . The MTT assay showed that overexpression of CRNDE significantly promoted proliferation of GC cells compared with normal controls (Fig. 2B) . Proliferation of GC cells was significantly inhibited when CRNDE was silenced (Fig.  2D) . Similarly, increased CRNDE expression was associated with formation of significantly more colonies of GC cells than in negative controls (Fig. 2E) . Significantly fewer colonies formed in cultures of LV-shCRNDE GC cells than were seen in the negative control cells (Fig.  2F) . Furthermore, GES-1 cells which have relatively lower endogenous CRNDE were infected with LV-CRNDE or LV-NC (Fig. 2G) . Consistent with the above observations, up-regulating the expression of CRNDE results in increased viability and colony-formation ability of GC cells ( Fig. 2H and I) . These results confirmed the oncogenic role of CRNDE in GC.
CRNDE acts as a molecular sponge of miR-145
The ceRNA hypothesis presumes that specific lncRNA can act as sinks for pools of active miRNAs, functionally liberating mRNA transcripts targeted by that set of miRNAs. To determine whether CRNDE acted as a ceRNA, we used miRcode-target (http://www. mircode.org/) to predict potential lncRNA-miRNA interactions. We found that miR-145 was significantly decreased in SGC-7901 and BGC-823 cells treated with LV-CRNDE, and was among several miRNAs that had high predicted CRNDE binding high scores (Fig. 3A) .
miRNAs have previously been shown to be present as miRNA ribonucleoprotein complexes that contain Ago2, the key RISC component [15, 16] . To test whether CRNDE associated with a RISC complex, we examined miR-145 and CRNDE on magnetic beads conjugated to anti-Ago2 antibody. We found that miR-145 was highly enriched in GC cells (Fig. 3B) , suggesting that CRNDE may act by deregulating miR-145. In addition, the activity of luciferase reporters containing the putative binding sequence of CRNDE in miR-145 was significantly decreased in CRNDE-WT constructs compared with CRNDE-Mut constructs, which were not affected ( Fig. 3C and D) . Furthermore, miR-145 expression was significantly decreased in GC tissues compared with that in adjacent normal tissue samples (Fig. 3E ), and miR-145 level had a significant negative correlation with CRNDE level (Fig.3F) . Collectively, the results suggest that miR-145 was targeted by CRNDE.
miR-145 reverses the promoting effects of CRNDE on GC cells
To investigate whether the effects of miR-145 on cell proliferation were mediated by CRNDE, we transfected SGC-7901 and BGC-823 cells with miR-145 mimics and a CRNDE expression vector. The MTT assays showed that miR-145 abrogated the promotion of cell proliferation (Fig. 4A ) and cell culture showed that colony formation was also inhibited (Fig. 4B ). These observations suggest that CRNDE promoted tumor cell growth in part by competitively binding miR-145.
CRNDE modulated expression of endogenous miR-145 targets E2F3
miR-145 has been reported to target and repress E2F3 expression in human GC [17] . To confirm whether CRNDE promoted GC progression by targeting miR-145, we evaluated the effect of CRNDE on E2F3. We found that E2F3 protein, but not mRNA, expression was significantly enhanced in SGC-7901 and BGC-823 cells transfected with LV-CRNDE-WT, whereas LV-CRNDE-Mut had no significant effect on E2F3 expression (Fig. 5A and B) . When we transfected SGC-7901 and BGC-823 cells with LV-shCRNDE, E2F3 protein, but not mRNA expression, was significantly reduced following CRNDE downregulation (Fig. 5C and D) . SGC-7901 and BGC-823 cells were transfected with the vector, LV-CRNDE, or LV-CRNDE combined with miR-145 mimics to investigate the effect of miR-145 repression on E2F3 expression. E2F3 protein, but not mRNA, expression was increased by CRNDE, and that effect was partially repressed by miR-145 mimics ( Fig. 5E and F) . These results show that CRNDE abrogated the repression of E2F3 induced by miR-145 by sequestering endogenous miR-145, and exerted oncogenic functions by modulating miR-145/E2F3.
Discussion
Recent evidence of the role of noncoding RNAs in cancer pathogenesis has added to our understanding of the biology of this disease [7, [18] [19] [20] , and in the past decade, study of miRNAs has dominated the field of noncoding RNA regulation. Recently, accumulated evidence on lncRNA has indicated that dysregulation of lncRNA may not only affect the regulation of the eukaryotic genome, but also provide a growth advantage to malignant cells, resulting in progressive and uncontrolled tumor growth [21, 22] . Therefore, lncRNAs may provide a missing piece to help complete the puzzle of the oncogenic and tumor suppressor network.
CRNDE is located on chromosome 16, and was initially identified as an lncRNA in colorectal cancer. Its expression is significantly upregulated in colorectal cancer, where it is involved in cell proliferation, migration, and invasion [10] . A transcript isoform (CRNDE-h) found in patient plasma may serve as a biomarker [23] . The CRNDE lncRNA is also strongly upregulated in glioma, and contributes to disease progression by promoting cell proliferation, migration and invasion by mTOR signaling [24] . CRNDE is also overexpressed in melanoma and lymphocytic leukemia cells.
The activity of CRNDE in GC has not been previously described. In this study, we found that CRNDE was upregulated in GC cells and tissues, and overexpression significantly promoted cell proliferation and colony formation, whereas knockdown of CRNDE negatively regulated cell growth. The findings show that CRNDE played an important role in the modulation of GC progression, and warrant further research on CRNDE as a therapeutic target in GC.
Increasing numbers of reports reveal the existence of a widespread interaction network involving ceRNAs, where ncRNAs could regulate modulatory RNA by binding and titrating them off their binding sites on protein coding messengers [6, 25] . This type of regulation has been shown by H19, NEAT1, ROR and PCGEM1 [26] [27] [28] [29] . We hypothesized that lncRNA CRNDE functioned as a ceRNA to promote GC progression, and looked for potential interactions with miRNAs. We used bioinformatics analysis and luciferase assays to verify the direct binding of predicted miRNA response elements on the CRNDE transcript. The results showed that miR-145 could form complementary base pairing with CRNDE and could reduce expression of a pGL3-CRNDE reporter gene. In the RIP assay, expression of CRNDE immunoprecipitated with Ago2 was higher than that immunoprecipitated with IgG, indicating a reciprocal repression of CRNDE and miR-145 caused by RISC. We also showed that miR-145 expression level was negatively correlated with CRNDE level in GC tissue and that miR-145 overexpression arrested GC cell growth. The findings demonstrate that CRNDE interacted with miR-145 in GC pathogenesis.
miR-145 in known to inhibit tumor progression and metastasis by downregulating E2F3 in human GC [17] , and to show the miRNA-related activity of CRNDE in GC pathogenesis, we evaluated its effect on E2F3, which is a target of miR-145.The E2F family of transcription factors regulates both cellular proliferation and differentiation, and E2F3 is a key transcriptional factor of genes that control the proliferation rate of both primary and tumor cells [30] . A number of studies have reported that E2F3 is targeted by various miRNAs and is involved in the genesis and progression of human cancers [31] [32] [33] [34] . Our study showed that E2F3 expression was significantly increased by upregulating CRNDE expression, whereas shCRNDE significantly decreased E2F3 expression. The results indicate that CRNDE oncogenesis involved functioning as a ceRNA to regulate E2F3 expression by sponging miR-145 in GC.
In summary, we showed that the lncRNA CRNDE promoted GC cell proliferation by competitively binding miR-145, and described a novel CRNDE/miR-145/E2F3 signaling pathway with a regulatory function in GC. The findings show that CRNDE may be a target for GC therapy, with the crosstalk between miR-145, CRNDE and E2F3 shedding new light on potential treatment of GC.
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